„We must learn to create magical spheres that ... only hit the pathogens.”
Paul Ehrlich 1854-1915
JOINT INTERVIEW WITH bmIt: What was so special about the start-up? What was the early phase of the company's foundation like? bmIt investment manager Stefan Jahn and managing director Dr. Marc Lehmann jointly answered these and more questions from the Thüringer Aufbaubank.
"SPOTLIGHT ON INNOVATION": The motto of this year's Investor Days Thuringia said it all. After two years without a presence event, the start-ups were allowed to pitch live on stage again. SmartDyelivery presented itself as a growth company during the two-day event in Erfurt's stadium.
DEVELOPMENT OF NEW THERAPY OPTIONS
In a first field of application we focus on the targeted transport of active substances in liver cells. We are thus creating a therapeutic option for the treatment of patients with septic cholestasis with the aim of reducing the extremely high mortality rate caused by this complication.